-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Soleno Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
- Soleno Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.9M, a 188% decline year-over-year.
- Soleno Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$72.6M, a 151% decline year-over-year.
- Soleno Therapeutics Inc annual Operating Income (Loss) for 2023 was -$41.4M, a 69.6% decline from 2022.
- Soleno Therapeutics Inc annual Operating Income (Loss) for 2022 was -$24.4M, a 22.6% increase from 2021.
- Soleno Therapeutics Inc annual Operating Income (Loss) for 2021 was -$31.5M, a 13.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)